Presentation is loading. Please wait.

Presentation is loading. Please wait.

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12- month follow-up analysis  Pranabashis Haldar, MD, Christopher E. Brightling,

Published byDan Lorentzen Modified over 5 years ago

Similar presentations

Presentation on theme: "Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12- month follow-up analysis  Pranabashis Haldar, MD, Christopher E. Brightling,"— Presentation transcript:

1 Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12- month follow-up analysis  Pranabashis Haldar, MD, Christopher E. Brightling, PhD, Amisha Singapuri, BSc, Beverley Hargadon, BSc, Sumit Gupta, PhD, William Monteiro, BSc, Peter Bradding, PhD, Ruth H. Green, MD, Andrew J. Wardlaw, PhD, Hector Ortega, PhD, Ian D. Pavord, DM  Journal of Allergy and Clinical Immunology  Volume 133, Issue 3, Pages (March 2014) DOI: /j.jaci Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Comparison of change in inflammatory parameters, severe exacerbation rate, and clinical measures between study groups. Variable measurements presented are the group mean, with error bars representing the standard error of the mean at the time of study entry (prestudy), at the end of the treatment phase (end of study), and at sequential visits during the 12-month observation period. Blood and sputum eosinophil counts and Feno are presented as the geometric mean, with error bars representing log standard error of the mean. Feno, Fraction of exhaled nitric oxide. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig E1 Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12- month follow-up analysis  Pranabashis Haldar, MD, Christopher E. Brightling,"

Similar presentations

Thank You This PowerPoint document contains the images that you requested. Copyright Notice All Online Service materials, including, without limitation,

Thank You This PowerPoint document contains the images that you requested. Copyright Notice All Online Service materials, including, without limitation,
Buffering airway acid decreases exhaled nitric oxide in asthma Benjamin Gaston, MD, Robin Kelly, RN, Peter Urban, RN, Lei Liu, PhD, Edward M. Henderson,

Buffering airway acid decreases exhaled nitric oxide in asthma Benjamin Gaston, MD, Robin Kelly, RN, Peter Urban, RN, Lei Liu, PhD, Edward M. Henderson,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life  Carina Venter, BSc, Brett Pereira, MRCP, Jane.

Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life  Carina Venter, BSc, Brett Pereira, MRCP, Jane.
Alveolar nitric oxide and asthma control in mild untreated asthma

Alveolar nitric oxide and asthma control in mild untreated asthma
Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity  Andrei Malinovschi,

Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity  Andrei Malinovschi,
Risk of an asthma exacerbation after bariatric surgery in adults

Risk of an asthma exacerbation after bariatric surgery in adults
Reduced exhaled nitric oxide values in children with asthma after inpatient rehabilitation at high altitude  Johannes Huss-Marp, MD, Ursula Krämer, PhD,

Reduced exhaled nitric oxide values in children with asthma after inpatient rehabilitation at high altitude  Johannes Huss-Marp, MD, Ursula Krämer, PhD,
Pharmacologic rationale for treating allergic and nonallergic rhinitis

Pharmacologic rationale for treating allergic and nonallergic rhinitis
Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S

Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S
Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life  Carina Venter, BSc, Brett Pereira, MRCP, Jane.

Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life  Carina Venter, BSc, Brett Pereira, MRCP, Jane.
Alalia Berry, MD, William W. Busse, MD 

Alalia Berry, MD, William W. Busse, MD 
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Current application of exhaled nitric oxide in clinical practice

Current application of exhaled nitric oxide in clinical practice
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents

Desensitization to Chemotherapeutic Agents
Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: A random-sample population study  Asger Sverrild, MD, Celeste Porsbjerg,

Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: A random-sample population study  Asger Sverrild, MD, Celeste Porsbjerg,
Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol  Ian D. Pavord, DM, FRCP, Peter K. Jeffery,

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol  Ian D. Pavord, DM, FRCP, Peter K. Jeffery,
Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma  Christopher Newby, PhD, Joshua Agbetile, MRCP,

Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma  Christopher Newby, PhD, Joshua Agbetile, MRCP,

Similar presentations

Ads by Google